NIMR in collaboration with Afe Babalola University, Ado Ekiti (ABUAD) is evaluating the safety and efficacy of Virucidine, a Nigerian herbal medicine for management of COVID-19. Participants’ recruitment starts in the last week of February 2022.
Interested adults diagnosed with COVID-19 who want to participate in the study can contact the study focal person on
08033220631
nkiru_d@yahoo.com for further details.
The use of MGI ATOPlex Technology for Complete
Genome Sequencing and Identification of
SARS-CoV-2 Variants on DNBSEQ-G50* in Nigerian
Institute of Medical Research
Dr. Sam Amoo of NIMR (5th from left) in a group photograph with the National Blood Service Commission (NBSC) Team led by Dr. Adaeze Oreh (6th from the left) Head of planning, research and statistics (NBSC) during his visit to the Agency in Abuja to foster research collaboration on Safety and Efficacy of blood used for transfusion and discussion about the digitalization of donor retention system for voluntary blood donors in Nigeria.
The Director-General of NCDC Dr. Ifedayo M. O Adetifa (1st from right) on a familiarization visit to NIMR to strengthen collaborations between the two institutions.
He was received by the DG/CEO, Prof. Babatunde Lawal Salako, the Management team, Senior Researchers and Inventors in NIMR on Thursday, 6th January 2022.
